this report to describe the changes in the coagulation mechanism in 4 children with severe varicella infection, 3 of whom had hemorrhagic chickenpox. All cases had a malignant disease at the time of their viral infection; 2 with acute leukemia in remission, 1 acute leukemia in relapse, and 1 with metastatic retinoblastoma. All were receiving an antineoplastic drug but none were on corticosteroids. None had bacterial sepsis or shock at the time of their chickenpox. Hemorrhagic varicella only occurred in the 3 leukemic patients, and all 3 died. The non-hemorrhagic case survived. The coagulation data revealed that the patients with the hemorrhagic form demonstrated thrombocytopenia, reduced levels of coagulation factors II, V, and VIII, hypofibrinogenemia, positive fibrin split products, and normal euglobulin lysis. In the non-hemorrhagic patient all studies were normal. Heparin therapy was given to one patient with questionable improvement only noted in the fibrinogen level. Although hepatic necrosis may be found in fatal cases of varicella the coagulation data suggest that the multiple defects were due to DIC. In addition, the data further suggest that the mechanism by which this virus elicits DIC is different from bacterial sepsis since the DIC was clearly present in the absense of hypotension or shock. Kerosene ingestion, a common cause of accidental poisoning in children, is often followed by serious bacterial pulmonary infection. The effect of kerosene ingestion (10 ml/kg) on pulmonary antibacterial defense mechanisms was studied acutely (4 hr) and subacutely (24 hr) in pretreated mice exposed to an aerosol inoculum of radiotracer-tagged ( 32 P) Staphylococcus aureus. Intrapulmonary bacterial inactivation was determined by quantitating the change in bacterial viability and isotope clearance in the lungs of each animal. Controls inactivated 86.6 ± 1.0% of the inoculum. Kerosene ingestion resulted acutely in a depression of host defenses, with only 59.1 ± 4.5% of the inhaled bacteria cleared. In animals challenged with aerosolized bacteria 24 hours after kerosene ingestion, intrapulmonary bacterial replication exceeded inactivation and bacterial clearance did not return to normal until 96 hours after ingestion. Pulmonary histology, correlated with bacterial clearance, revealed a chemical pneumonitis, with alveolar hemorrhage, bronchial necrosis and pulmonary edema. Aspiration of the ingested kerosene increased the severity of the anatomical and functional alterations. Similar structural and functional responses were demonstrated following ingestion of other toxic agents commonly ingested by children, with acute and subacute inactivation values of 70.5 ± 3.9% and 32.2 ± 11.7% for linseed oil, 46.3 ± 5.6% and 70.4 ± 4.8% for gasoline, 73.4 ± 2.9% and 70.6 ± 5.7% for lighter fluid and 54.3 ± 6.5% and 71.3 ± 3.2% for turpentine.
The unusual severity of mycoplasmal pneumonia in children with sickle cell disease. S. T. SHULMAN, J. BARTLETT, W. CLYDE, and E. M. AYOUB. Univ. Fla., Gainesville, Fla.; Univ. of North Carolina, Chapel Hill, N.C. Respiratory infection with Mycoplasma pneumoniae in children is uniformly considered to be mild and benign. Patients with sickle cell disease may have frequent episodes of pulmonary infection and/or infarction and are known to be unusually susceptible to pneumococcal disease including overwhelming sepsis. We recently observed 4 children (ages 4-12 years) with sickle cell disease who had pulmonary infection attended by a severe course of illness. Clinical features included diffuse pneumonia (4 patients), pleural effusion (2), prolonged febrile states (3), respiratory distress (3), moderate to marked leukocytosis (4) and pleuritic pain (3). None of these patients responded to penicillin and/or ampicillin. All 4 patients had significantly elevated cold hemagglutinin titers. M. pneumoniae was isolated from both patients cultured for this organism. In 3 patients serologic evidence of M. pneumoniae infection, as manifested by a rise in the mycoplasma complement fixation (CF) or growth inhibition (GI) titer, was obtained. One patient showed no rise in CF titer but an elevation of the GI titer. The course of this disease was of a severity rarely observed in M. pneumoniae infection. The reason for the unusual severity of this ordinarily benign disease in this group of patients is not clear at present but may be related to concomitant pulmonary infarction or to an underlying immune defect. In addition to pulmonary infarction and pneumococcal infection, the differential diagnosis of pulmonary disease in patients with sickle cell disease and leukocytosis must include mycoplasmal infection, especially when penicillin unresponsiveness is noted.
The EB virus infection within families of cases of infectious mononucleosis. J. H. JONCAS (Intr. by J. R. Ducharme). Univ. of Montreal and I'Hopital Ste-Justine, Montreal, Que., Canada.
The incidence and rise of the EBV antibodies were measured by indirect immunofluorescence in 1033 sera from a group of 175 pediatric and older cases of infectious mononucleosis and from 344 family and social contacts. Cases of infectious mononucleosis with eleven exceptions were EBV seropositive in acute and/or convalescent sera. A rise in EBV antibodies of two dilutions or more was demonstrated in 23 of the 175 cases. The EBV antibody titres of mononucleosis sera were significantly higher than those of contacts's sera (P < 0.01). The incidence of these antibodies in contacts reached 35 to 67% in four different age groups. A seroconversion was demonstrated in only 9 of 110 EBV negative family contacts and a significant antibody rise encountered in only 6 additional contacts giving an attack rate of less than 15%. Interinfection or interdisease periods varied from 1 week to 2 years. The infectivity of the EB virus and its horizontal transmission seem to be as low in nature as they appear to be experimentally in the laboratory. The epidemiological behaviour of the EB virus infection suggests that its relationship to infectious mononucleosis may be analogous to that of the V-Z virus to zoster. It is difficult in most cases to differentiate clinically among perinatal infections associated with Toxoplasma (To), Rubella (R), Cytomegalovirus (C) and Herpes simplex virus, type 1 or 2 (H). To evaluate this problem, sera submitted to CDC from infants (<2 yrs.) with various abnormalities were tested for all agents in the ToRCH complex, besides those requested by the physician. Antibodies to To, R and C were measured by conventional technics, and antibodies to H type 1 and 2 by microneutralization and IgM fluorescent antibody tests. Interpretation of results were complicated by such factors as prior immunization,
